Nirmatrelvir drug for Covid-19, molecular model. Nirmatrelvir is an antiviral medication developed to treat Covid-19. The drug is a protease inhibitor that acts on the spike protein of the SARS-CoV-2 virus. Paxlovid, a combination drug of nirmatrelvir and the antiviral ritonavir is currently in Phase III testing. Atoms are colour-coded: carbon is black; hydrogen is white; nitrogen is blue; oxygen is red. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / GREG WILLIAMS |
Bildgröße: | 4500 px × 4500 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |